NCT05968690 2025-09-18
Naltrexone and Propranolol Combined With Immunotherapy
Rutgers, The State University of New Jersey
Phase 1 Recruiting
Clinical Trials
4 trialsNCT01988831 2019-05-10
Efficacy of Propranolol Treatment to Prevent Melanoma Progression
University Hospital, Geneva
Phase 2 Suspended
NCT01705392 2017-02-24
Bevacizumab vs Dacarbazine in Metastatic Melanoma
Haukeland University Hospital
Phase 2 Terminated
NCT02962947 2016-11-15
MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients
Azienda Sanitaria di Firenze
Phase 2/3 Unknown